Modulation of CCR4 function
US7262204B2 · kind B2 · utility
87Cited by
14References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 2, 2003 |
| Grant date | Aug 28, 2007 |
| Priority date | — |
| Expiry date | Sep 18, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and compositions are provided that bind to the CCR4 chemokine receptor and which are useful for treating diseases associated with CCR4 activity, such as contact hypersensitivity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.